Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Xiaojing Pang, Xiujuan Liu, Yuan Liu, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4250-4250
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

An overview of PROTACs: a promising drug discovery paradigm
Liu Zi, Mingxing Hu, Yang Yu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 129
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
Xiujuan Liu, Hong-Cheng Zhao, Su-Juan Hou, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106425-106425
Closed Access | Times Cited: 62
Annual review of PROTAC degraders as anticancer agents in 2022
Xiao Wang, Zhao-Long Qin, Na Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116166-116166
Closed Access | Times Cited: 41
Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 19
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment
Xianbo Wu, Jie Wang, Qi Liang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113116-113116
Open Access | Times Cited: 35
Antitumor Activity of s-Triazine Derivatives: A Systematic Review
Qiuzi Dai, Qinsheng Sun, Xiaorong Ouyang, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4278-4278
Open Access | Times Cited: 24
Focal adhesion kinase (FAK): its structure, characteristics, and signaling in skeletal system
Yuping Huang, Junguang Liao, Rexhina Vlashi, et al.
Cellular Signalling (2023) Vol. 111, pp. 110852-110852
Closed Access | Times Cited: 21
A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115673-115673
Closed Access | Times Cited: 20
Quaternary Ammonium Compounds and Their Composites in Antimicrobial Applications
Yining Yao, Zilin Ye, Yue Zhang, et al.
Advanced Materials Interfaces (2024) Vol. 11, Iss. 17
Closed Access | Times Cited: 9
Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer
Blair McNamara, Cem Demirkiran, Tobias M.P. Hartwich, et al.
Gynecologic Oncology (2024) Vol. 183, pp. 133-140
Closed Access | Times Cited: 8
Focal Adhesion Regulation as a Strategy against Kidney Fibrosis
Jiwen Geng, Kaikai Zheng, Peng Wang, et al.
ACS Chemical Biology (2025)
Closed Access
The dawn of precision medicine in diffuse-type gastric cancer
Akira Ooki, Kensei Yamaguchi
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 28
Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 4
Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy
Xiujuan Liu, Xu-Liu, Xiaojing Pang, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 47, pp. 116358-116358
Closed Access | Times Cited: 32
Dual roles of FAK in tumor angiogenesis: A review focused on pericyte FAK
Jingyu Zhang, Wěi Li, Wenxin Wang, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175694-175694
Closed Access | Times Cited: 12
Survival mechanisms of circulating tumor cells and their implications for cancer treatment
Shuang Zhou, Huanji Xu, Yichun Duan, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 3
The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo
Jian Song, Xu Liu, Yifan Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106328-106328
Closed Access | Times Cited: 16
Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors
Zhiwu Long, Yaqing Zuo, Rongrong Li, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106792-106792
Closed Access | Times Cited: 8
Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas
Cem Demirkiran, Michelle Greenman, Stefania Bellone, et al.
Gynecologic Oncology (2024) Vol. 187, pp. 12-20
Closed Access | Times Cited: 2
Molecular Docking, Molecular Dynamics Simulations, and Free Energy Calculation Insights into the Binding Mechanism between VS-4718 and Focal Adhesion Kinase
Mingsong Shi, Tao Chen, Siping Wei, et al.
ACS Omega (2022) Vol. 7, Iss. 36, pp. 32442-32456
Open Access | Times Cited: 14
Lipopolyplex-Mediated Co-Delivery of Doxorubicin and FAK siRNA to Enhance Therapeutic Efficiency of Treating Colorectal Cancer
Tilahun Ayane Debele, Chi-Kang Chen, Lu-Yi Yu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 596-596
Open Access | Times Cited: 7
Discovery of novel pyrrolo [2,3-d] pyrimidine derivatives as potent FAK inhibitors based on cyclization strategy
Shenxin Zeng, Shuai Yuan, Yu Zhang, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106713-106713
Closed Access | Times Cited: 7
Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities
Yang Liu, Lijun Kong, Na Li, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106895-106895
Closed Access | Times Cited: 7
FTO facilitates cancer metastasis by modifying the m6A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer
Lirong Gao, Anqi Wang, Yuling Chen, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
The mechanical cell – the role of force dependencies in synchronising protein interaction networks
Benjamin T. Goult, Magdaléna von Essen, Vesa P. Hytönen
Journal of Cell Science (2022) Vol. 135, Iss. 22
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top